BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20831357)

  • 1. A cessation program for snuff-dippers with long-term, extensive exposure to Swedish moist snuff: A 1-year follow-up study.
    Wallström M; Bolinder G; Hassèus B; Hirsch JM
    Acta Odontol Scand; 2010 Nov; 68(6):377-84. PubMed ID: 20831357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smokeless tobacco cessation: report of a preliminary trial using nicotine chewing gum.
    Sinusas K; Coroso JG
    J Fam Pract; 1993 Sep; 37(3):264-7. PubMed ID: 8409878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient management in a tobacco-cessation program in the dental practice.
    Crews KM; Johnson L; Nichols M
    Compendium; 1994 Sep; 15(9):1142, 1144, 1146 passim; quiz 1156. PubMed ID: 7987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco cessation, the dental profession, and the role of dental education.
    Christen AG
    J Dent Educ; 2001 Apr; 65(4):368-74. PubMed ID: 11336123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms of nicotine dependence in a cohort of Swedish youths: a comparison between smokers, smokeless tobacco users and dual tobacco users.
    Post A; Gilljam H; Rosendahl I; Bremberg S; Galanti MR
    Addiction; 2010 Apr; 105(4):740-6. PubMed ID: 20148785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine gum in smoking cessation: rationale, efficacy, and proper use.
    Schneider NG
    Compr Ther; 1987 Mar; 13(3):32-7. PubMed ID: 3568597
    [No Abstract]   [Full Text] [Related]  

  • 7. Tobacco cessation for the dental team: a practical guide part II: evidence-based interventions.
    Davis JM
    J Contemp Dent Pract; 2005 Nov; 6(4):178-86. PubMed ID: 16299620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
    Biazzo LL; Froshaug DB; Harwell TS; Beck HN; Haugland C; Campbell SL; Helgerson SD
    Nicotine Tob Res; 2010 Jun; 12(6):567-73. PubMed ID: 20378640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation with smokeless tobacco and group therapy: an open, randomized, controlled trial.
    Tønnesen P; Mikkelsen K; Bremann L
    Nicotine Tob Res; 2008 Aug; 10(8):1365-72. PubMed ID: 18686184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of snus in initiation and cessation of tobacco smoking in Sweden.
    Ramström LM; Foulds J
    Tob Control; 2006 Jun; 15(3):210-4. PubMed ID: 16728752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco cessation and nicotine replacement therapy for dental practice.
    Christen AG; Jay SJ; Christen JA
    Gen Dent; 2003; 51(6):525-32. PubMed ID: 15055649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.
    Ebbert JO; Dale LC; Patten CA; Croghan IT; Schroeder DR; Moyer TP; Hurt RD
    Nicotine Tob Res; 2007 Jan; 9(1):43-52. PubMed ID: 17365735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine replacement as sole therapy or as adjunct.
    Jarvis M
    Prog Clin Biol Res; 1988; 261():145-62. PubMed ID: 3289003
    [No Abstract]   [Full Text] [Related]  

  • 14. [Smoking cessation--assistance for the general practitioner].
    Hering T
    MMW Fortschr Med; 2011 Apr; 153(14):67-9. PubMed ID: 21966874
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of tobacco use: a 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population.
    Lundqvist G; Sandström H; Ohman A; Weinehall L
    Scand J Public Health; 2009 Mar; 37(2):161-7. PubMed ID: 19039092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy.
    Jacob P; Hatsukami D; Severson H; Hall S; Yu L; Benowitz NL
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1668-73. PubMed ID: 12496059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Employment, gender, and smoking cessation outcomes in low-income smokers using nicotine replacement therapy.
    Burgess DJ; Fu SS; Noorbaloochi S; Clothier BA; Ricards J; Widome R; van Ryn M
    Nicotine Tob Res; 2009 Dec; 11(12):1439-47. PubMed ID: 19875765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.
    Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI
    Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telephone counseling as adjuvant treatment for nicotine replacement therapy in a "real-world" setting.
    Zhu SH; Tedeschi G; Anderson CM; Rosbrook B; Byrd M; Johnson CE; Gutiérrez-Terrell E
    Prev Med; 2000 Oct; 31(4):357-63. PubMed ID: 11006060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing nicotine substitutes for tobacco cessation: considerations and contraindications.
    Salinas TJ; Jacob RF
    Tex Dent J; 1994 Jun; 111(6):33-5, 37. PubMed ID: 8633292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.